TITLE

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study

AUTHOR(S)
Likosky, W H; Fireman, B; Elmore, R; Eno, G; Gale, K; Goode, G B; Ikeda, K; Laster, J; Mosher, C; Rozance, J
PUB. DATE
December 1991
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Dec1991, Vol. 54 Issue 12, p1055
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66078320

 

Related Articles

  • High-Dose, Myeloimmunoablative Chemotherapy Followed by Autologous Stem Cell Transplantation in the Treatment of MS. Fassas, Athanasios // Multiple Sclerosis (13524585);Dec2000, Vol. 6 Issue 6, p421 

    Examines the therapeutic efficacy of high-dose myelo/immunosuppressive therapy and stem cell transplantation in chronic progressive multiple sclerosis (MS). Composition of the treatment regimen used; Toxicities observed in patients studied; Probability of confirmed progression-free survival in...

  • Scientific Session 11 Is there a role of intensive immunosuppression in multiple sclerosis?  // Multiple Sclerosis (13524585);Jan99 Supplement 1, Vol. 5 Issue 1, pS14 

    Presents summaries of several studies on immunosuppression in multiple sclerosis. 'Intensive Immunosuppression in MS: Toxicity vs Efficacy,' by R.E. Gonsette; 'Is There a Role of Intensive Immunosuppression in MS? Prospects of Combinations,' by G. Edan; 'Autologous Stem Cell Transplantation:...

  • Is there a role of intensive immunosuppression in multiple sclerosis?  // Multiple Sclerosis (13524585);Sep99 Supplement, Vol. 5, pS14 

    The article presents abstracts of medical research related to multiple sclerosis. They include "Intensive Immunosuppression in MS: Toxicity vs Efficacy," "Autologous Stem Cell Transplantation: Clinical Results and Future Activities," and "Mitoxantrone in Progressive Multiple Sclerosis (MS):...

  • Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Wang, J.; Han, Z.; Sun, L. // Multiple Sclerosis (13524585);May2009, Vol. 15 Issue 5, p644 

    Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system. Umbilical cord derived mesenchymal stem cells are immunosuppressive. We transplanted mesenchymal stem cells in a patient with refractory progressive MS, and the disease course was stabilized after the...

  • Improving on existing therapies.  // Multiple Sclerosis (13524585);Sep2005 Supplement, Vol. 11, p9 

    Discusses abstracts of studies about the treatment of multiple sclerosis, published in the October 2005 issue of the periodical "Multiple Sclerosis". "Early Treatment," by X. Montalban; "Mitoxantrone Treatment in MS Patients: A Five-Year Clinical and MRI Follow-Up," by C. Buttinelli and...

  • Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Capello, E.; Saccardi, R.; Murialdo, A.; Gualandi, F.; Pagliai, F.; Bacigalupo, A.; Marmont, A.; Uccelli, A.; Inglese, M.; Bruzzi, P.; Sormani, M.; Cocco, E.; Meucci, G.; Massacesi, L.; Bertolotto, A.; Lugaresi, A.; Merelli, E.; Solari, A.; Filippi, M.; Mancardi, G. // Neurological Sciences;Dec2005 Supplement 4, Vol. 26, ps200 

    Aggressive forms of multiple sclerosis (MS) represent a limited group of demyelinating diseases that rapidly progress to severe disability. Currently available therapies are poorly effective against these clinical entities. Recently, it has been demonstrated that intense immunosuppression...

  • Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis. Axelsson, Markus; Malmeström, Clas; Gunnarsson, Martin; Zetterberg, Henrik; Sundström, Peter; Lycke, Jan; Svenningsson, Anders // Multiple Sclerosis Journal;Jan2014, Vol. 20 Issue 1, p43 

    The article discusses a study which investigated the effect on cerebrospinal fluid (CSF) biomarkers of axonal damage, astrogliosis, and B-cell regulation following immunosuppressive therapy with mitoxantrone or rituximab in progressive multiple sclerosis (PMS). The study included 35 patients...

  • Updates in Multiple Sclerosis: 9th Meeting of the Centro Studi Sclerosi Multipla-Gallarate and 2nd Meeting of the SIN Multiple Sclerosis Study Group.  // Neurological Sciences;Jul2006, Vol. 27 Issue 3, p209 

    The article presents abstracts on multiple sclerosis research. They include "The Chronic-Progressive Phase of Multiple Sclerosis: Clinical Point of View," "Cognitive Functioning in Childhood and Juvenile Multiple Sclerosis" and "Pregnancy Outcomes During Therapy With Disease-Modifying Drugs in...

  • Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon? Weilbach, F.X.; Gold, R. // CNS Drugs;1999, Vol. 11 Issue 2, p133 

    Stimulated by the successful introduction of interferon-β as treatment for relapsing-remitting multiple sclerosis (MS) and based on an improved knowledge of the immunopathology of MS, a vast array of treatment options is currently under investigation for disease course modification. These are...

  • Therapy — immunomodulation — Part I.  // Multiple Sclerosis (13524585);Sep2005 Supplement, Vol. 11, p75 

    Discusses abstracts of studies about immunomodulation and multiple sclerosis, published in the October 2005 issue of the periodical "Multiple Sclerosis". "Prevention of Chronic Black Holes With Interferon Beta-1a in Secondary Progressive MS," by A. Traboulsee and colleagues; "Design and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics